Пошук торговельних марок

Discovery Life Sciences, LLC
900 Hudson Way, ATTN: Legal Dept.
Huntsville AL 35806 (US)

Англ. Purple and orange.

Англ. The mark consists of The mark consists of a stylized molecule image and the words "DISCOVERY LIFE SCIENCES" on two lines. The purple color appears on the words "Discovery Life Sciences", as well as on the molecule image. The orange color appears on the molecule image.

Англ.Biological tissue, namely, blood, stem cells for scientific, laboratory or medical research, biological tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; cells for scientific, laboratory or medical research; cell culture media for scientific and research use; drug metabolism enzymes for use in toxicological research and pharmaceutical research and development; enzymes for scientific and research purposes; cell microsomes for scientific research use; human and animal primary cells for scientific research; reagents for research purposes; reagents for scientific or medical research use; stem cells for research or scientific purposes; stem cells for research purposes.

Англ.Nutritive substances for microorganism cultures; human hematology and immunology cells for medical and clinical use.

Англ.Biomedical services, namely, the storage of human biological specimens for medical use.

Англ.Medical and scientific research services in the field of biological tissue; medical and scientific research information in the field of primary cell biology, stem cell biology, toxicology, drug development, research reagents, cells, cell culture, and the development of research; laboratory research testing services in the field of drug metabolism; medical laboratory services (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations), namely collecting and processing of human and animal hematopoietic and immunological cells; research consultation, research and development services for drug discovery and development; pharmaceutical drug development services, namely, cell-based assay services, namely, of drug target validation, drug screening, predictive toxicology, cell viability, cell physiology, functional assays, stem cell assays, colony forming assays, cell culture, and primary cell characterization; flow cytometry services (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); immunophenotyping services (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); validation of cell separation devices for clinical use (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); immunoassay testing services (Term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); laboratory research in the field of primary cell biology, stem cell biology, toxicology, drug development, research reagents, cell culture, and the development of research tools for same; research and development and consultation related thereto in the field of primary cell biology, stem cell biology, toxicology, drug development, research reagents, cells, cell culture, and the development of research tools for same; custom design and development of cell-based assays; fee-for-service commercial nonclinical sequencing of human genetic material for scientific and medical research purposes.